5 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Terminated 5 |
Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ANTES B+ Clinical Trial Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Brimica, Duaklir - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Fundacio Privada Mon Clinic Barcelona | 48 | 2024-02-29 | 2025-08-14 |
| Substudy of Protocol 2019-002498-80 - NCT04223050: Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation (O2flow-COPD) Oxygen - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Mikkel Brabrand | 23 | 2021-12-16 | 2025-03-11 |
| Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease Inhaled Fluticasone Propionate - Asthma, Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | VA Office of Research and Development | 25 | 2013-03-12 | 2020-02-05 |
| Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients Salbutamol + Tiotropium, Placebo + Tiotropium - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 20 | 2008-09-01 | 2012-07-17 |
| Modification Of Disease Outcome In COPD fluticasone 500 mcg, fluticasone 500 mcg + salmeterol 50 mcg - Chronic Obstructive Pulmonary Disease | Phase 4 | Terminated | Leiden University Medical Center | 200 | 2000-04-01 | 2006-01-20 |
Pulmonary Disease, Chronic Obstructive (5) · Asthma (1) · Sleep Apnea, Obstructive (1)
Chronic Disease (5) · Disease Attributes (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Respiratory Tract Diseases (5) · Apnea (1) · Bronchial Diseases (1) · Dyssomnias (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Respiration Disorders (1)
Salmeterol Xinafoate (2) · Tiotropium Bromide (2) · Albuterol (1) · Fluticasone (1) · Formoterol Fumarate (1) · GSK573719 (1) · Glycopyrrolate (1) · Oxygen (1) · indacaterol (1) · olodaterol (1) · tiotropium-olodaterol (1)
Fundacio Privada Mon Clinic Barcelona (1) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Leiden University Medical Center (1) · Mikkel Brabrand (1) · VA Office of Research and Development (1)
Denmark (1) · Italy (1) · Netherlands (1) · Spain (1) · United States (1)
Mihaela Teodorescu, MD (1) · Peter J. Sterk, MD, PhD (1)
PMID 18039368, PMID 19841453, PMID 23667615, PMID 25836351, PMID 26659582, PMID 26696093, PMID 33060632, PMID 35118915, PMID 40739568
2019 (1), 2023 (1)